P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription

Maurizio Giannì1, Edoardo Parrella, Ivan Raska

  • 1Laboratorio di Biologia Molecolare, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italia.

The EMBO Journal
|February 4, 2006
PubMed

Insights

Retinoic acid receptors (RARs) control gene expression. Phosphorylation of coactivator SRC-3 by p38MAPK initially aids RARalpha activation but later inhibits transcription by promoting SRC-3 degradation.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Cell Signaling

Background:

  • Nuclear retinoic acid receptors (RARs) regulate gene expression through interactions with coregulators.
  • Ligand binding and phosphorylation are key regulatory processes in RAR activity.

Purpose of the Study:

  • To investigate the role of p38MAPK-mediated phosphorylation of the p160 coactivator SRC-3 in retinoic acid (RA)-dependent RARalpha gene activation.
  • To elucidate the dual role of SRC-3 phosphorylation in modulating RARalpha transcriptional activity.

Main Methods:

  • Studied RA-dependent activation of RARalpha isotype.
  • Investigated phosphorylation of p160 coactivator SRC-3 by p38MAPK.
  • Analyzed the impact of p38MAPK inhibition on RARalpha-mediated transcription and cell differentiation.

Main Results:

  • SRC-3 phosphorylation by p38MAPK initially facilitates RARalpha-target gene activation by altering coactivator-receptor interaction dynamics.
  • Subsequently, SRC-3 phosphorylation promotes its degradation, leading to transcriptional inhibition.
  • Inhibition of p38MAPK significantly enhances RARalpha-mediated transcription and RA-induced cell differentiation.
  • SRC-3 phosphorylation and degradation are specific to RARalpha complexes, suggesting an RAR isotype-dependent phosphorylation code.

Conclusions:

  • RARalpha transcriptional activity is regulated by SRC-3 through a mechanism involving coordinated phosphorylation and degradation events.
  • These events are fine-tuned by retinoic acid (RA) and p38MAPK signaling.
  • The RAR isotype dictates a phosphorylation code influencing coactivator accessibility to kinases like p38MAPK.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...